Genseq

Founded in 2015 and headquartered in Dublin, Genseq operates as a specialized service provider in the genetics and genomics space. Its core business is divided into two main segments: delivering accredited diagnostic testing for clinicians and providing R&D and trial support services to pharmaceutical and research organizations. The company leverages its ISO 15189 accredited laboratory to ensure high-quality, reliable data, positioning itself as a trusted partner in the precision medicine ecosystem. Genseq's model is built on enabling others in the healthcare continuum rather than developing its own therapeutics.

ISO 15189 accredited clinical laboratory utilizing next-generation sequencing, bioinformatics, and biobanking infrastructure to provide end-to-end genomic testing and sample management services.

Genseq competes in a fragmented but competitive market. It faces competition from large, diversified diagnostic and CRO giants (e.g., Labcorp, Quest Diagnostics, Eurofins), other specialized genomics service providers, and hospital-based academic laboratories. Its differentiation hinges on its ISO 15189 accreditation, customer service, and focus on the European market.